CytomX Therapeutics Inc logo

CytomX Therapeutics Inc

NEW
FRA:6C1 (USA)  
€ 2.802 +0.014 (+0.5%) Jul 28
At Loss
P/B:
2.19
Market Cap:
€ 615.66M ($ 705.23M)
Enterprise V:
€ 313.20M ($ 358.77M)
Volume:
0
Avg Vol (2M):
2.82K
Trade In:

CytomX Therapeutics Inc (FRA:6C1) Dividend

CytomX Therapeutics Inc (FRA:6C1) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -37%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:6C1 Dividend

Does CytomX Therapeutics Inc (FRA:6C1) pay a dividend?

CytomX Therapeutics Inc (FRA:6C1) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't CytomX Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. CytomX Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -37% over the past 3 years.

What are dividend-paying alternatives to CytomX Therapeutics Inc?

For dividend-paying alternatives in CytomX Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.